Natco Pharma Q4 net slips 34% to ₹269 cr. on formulation exports, shares fall 13.5%

Natco Pharma reported consolidated net profit for the March quarter declined nearly 34% to ₹269 crore compared with the ₹406 crore a year earlier on the back of a sharp fall in revenue from formulations export.

Raccontata daeconomictimes.indiatimes.comthehindubusinessline.comthehindu.com